STOCK TITAN

Manhattan Associates Inc Form 4 Filings

MANH NASDAQ

Every Form 4 that Manhattan Associates Inc (MANH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow MANH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MANH filings page.

Rhea-AI Summary

Manhattan Associates Inc. President & CEO Eric Andrew Clark reported a sale of 3,000 shares of common stock on 2026-08-11 in an open-market or private transaction at $197.76 per share. Following this transaction, he directly holds 89,638 shares of Manhattan Associates common stock.

Rhea-AI Summary

MANHATTAN ASSOCIATES INC director Linda T. Hollembaek reported a sale of company stock. On 2026-08-06, she sold 1,579 shares of common stock at an average price of $189.8801 per share in an open market or private transaction. Following this sale, she directly holds 12,268 shares of MANHATTAN ASSOCIATES INC common stock.

Rhea-AI Summary

Manhattan Associates Inc. executive James Stewart Gantt, EVP of Professional Services, reported selling 5,139 shares of Common Stock on 2026-07-30 in a sale described as an open market or private transaction at an average price of $195.5304 per share. Following this transaction, he directly holds 55,676 shares of the company’s Common Stock. The transaction was not reported as being conducted under a Rule 10b5-1 trading plan.

Rhea-AI Summary

MANHATTAN ASSOCIATES INC director Charles E. Moran reported a bona fide gift of 1,330 shares of Common Stock. The shares were transferred on June 15, 2026 to a revocable trust for no consideration, where he and his spouse serve as trustees. Following the transactions, he holds 1,940 shares directly and 22,138 shares indirectly through the trust.

Rhea-AI Summary

Manhattan Associates Inc. President and CEO Eric Andrew Clark reported an open-market sale of 1,000 shares of Common Stock at an average price of $146.7701 per share. Following this transaction, he directly holds 92,638 shares. This appears to be a routine, small reduction in his equity position.

Rhea-AI Summary

SHEER DANIELLE reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC director Danielle Sheer received a grant of 1,940 shares of Common Stock on May 14, 2026. The award was issued at no cash cost to her and is structured as restricted stock units under the company’s stock incentive plan. After this grant, she holds 3,270 shares directly. The units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, tying the award to continued board service over that period.

Rhea-AI Summary

Manhattan Associates director Kimberly A. Kuryea received an equity grant as part of her compensation. On May 14, 2026, she acquired 1,940 shares of common stock at no cost through a restricted stock unit award under the company’s stock incentive plan. The units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this grant, she directly holds 8,027 shares of Manhattan Associates common stock.

Rhea-AI Summary

Hollembaek Linda T. reported acquisition or exercise transactions in this Form 4 filing.

Manhattan Associates Inc. director Linda T. Hollembaek received a grant of 1,940 shares of common stock as restricted stock units under the company’s stock incentive plan. The award was at no cash cost per share and lifts her direct holdings to 13,847 shares, vesting fully on the earlier of the next annual shareholders’ meeting or the first anniversary of the grant date.

Rhea-AI Summary

Eger Edmond reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC director Edmond Eger reported an equity award of company stock. He received 1,940 shares of common stock as a restricted stock unit grant under the company’s stock incentive plan, reported at a transaction price of $0.00 per share.

The grant vests fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this award, Eger’s direct ownership stands at 8,453 shares of common stock.

Rhea-AI Summary

MORAN CHARLES E reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC director Charles E. Moran reported an equity award and updated holdings. He received a grant of 1,940 shares of Common Stock at $0.0000 per share as a compensation-related award, lifting his direct holdings to 3,270 shares. The award is a restricted stock unit grant under the company’s stock incentive plan, vesting fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Moran also reported 20,808 shares held indirectly by a trust, reflecting his indirect ownership position.

Rhea-AI Summary

NOONAN THOMAS E reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC director Thomas E. Noonan received a grant of 1,940 shares of common stock in the form of restricted stock units under the company’s stock incentive plan. The award vests in full on the earlier of the next annual shareholder meeting or the first anniversary of the grant date.

Following this equity award, Noonan directly holds 103,800 shares of Manhattan Associates common stock, reflecting routine, compensation-related stock-based pay rather than an open-market purchase.

Rhea-AI Summary

Capel Eddie reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC director Eddie Capel received 1,940 shares of Common Stock as a restricted stock unit grant. The award was made at no cash cost per share as part of the company’s stock incentive plan. Following this grant, Capel directly holds 156,329 shares of the company’s common stock.

The restricted stock units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, aligning director compensation with shareholder interests over that period.

Rhea-AI Summary

Manhattan Associates EVP James Stewart Gantt sold company stock in an open-market transaction. He sold 7,300 shares of Common Stock at an average price of $139.25 per share on April 24, 2026. After this sale, he directly holds 60,815 shares of Manhattan Associates common stock.

Rhea-AI Summary

MANHATTAN ASSOCIATES INC senior executive Linda C. Pinne, the SVP, CFO, CAO & Treasurer, received an equity award in the form of 5,323 shares of common stock as a grant or award acquisition. These are restricted stock units granted under the company’s stock incentive plan at no cash cost.

The units vest in stages, with 25% vesting on January 31 of each year following the grant date until fully vested. After this award, Pinne directly holds a total of 47,920 shares of MANH common stock, reflecting a routine compensation-related increase in her equity stake.

Rhea-AI Summary

Manhattan Associates EVP, CFO & Treasurer Dennis B. Story reported a tax-withholding disposition of 1,334 shares of common stock on February 28, 2026 at $135.43 per share. After this transaction, he directly owns 118,588 shares of Manhattan Associates common stock.

Rhea-AI Summary

Manhattan Associates Inc. senior vice president, chief legal officer and secretary Bruce Richards reported a Form 4 transaction involving company common stock. Richards disposed of 508 shares on February 28, 2026 at a price of $135.43 per share to cover tax obligations. Following this tax-withholding disposition, he directly owns 30,389 shares of Manhattan Associates common stock.

Rhea-AI Summary

Manhattan Associates senior vice president and global corporate controller Linda C. Pinne reported an automatic disposition of 75 shares of common stock on February 28, 2026. The transaction was a tax-withholding disposition at $135.43 per share, and she now directly holds 42,597 shares of the company.

Rhea-AI Summary

MANHATTAN ASSOCIATES INC executive Robert G. Howell reported a tax-related share disposition. On this Form 4, he disposed of 1,467 shares of common stock at an indicated price of $135.43 per share to satisfy tax withholding obligations. After this non-market transaction, he directly owns 177,706 shares.

Rhea-AI Summary

Manhattan Associates President and CEO Eric Andrew Clark reported a Form 4 showing a tax-related share disposition. On February 28, 2026, 1,595 shares of common stock were disposed of at $135.43 per share to cover tax obligations, leaving him with 93,638 shares owned directly.

Rhea-AI Summary

Manhattan Associates director Eddie Capel reported a tax-related share disposition. On this Form 4, he had 2,213 shares of common stock withheld at $135.43 per share to satisfy tax obligations. After this tax-withholding disposition, he still directly owns 154,389 common shares of the company.

Rhea-AI Summary

Manhattan Associates executive reports tax-related share disposition

Executive Vice President James Stewart Gantt reported a tax-withholding disposition of 1,467 shares of Manhattan Associates common stock at $135.43 per share on February 28, 2026. After this automatic share withholding for tax liability, he directly holds 68,115 shares of common stock.

Rhea-AI Summary

Manhattan Associates EVP, CFO & Treasurer Dennis B. Story reported acquiring additional common stock through equity awards. On January 22, 2026, he received two grant/award acquisitions of common stock totaling 9,421 and 2,556 shares at a price of $0.00 per share. Footnotes describe these as performance-based restricted stock units granted under the company’s stock incentive plan, with 25% vesting on February 28, 2026 and 25% on January 31 of each following year until fully vested. After these awards, he directly owned 115,795 shares of common stock, and a footnote states that he beneficially owns 119,922 shares including outstanding and unvested RSUs and performance-based RSUs.

Rhea-AI Summary

Richards Bruce reported acquisition or exercise transactions in this Form 4 filing.

MANHATTAN ASSOCIATES INC executive Bruce Richards, SVP, CLO & Secretary, reported two equity awards of common stock on January 22, 2026, totaling 4,568 shares. These are performance-based restricted stock units granted under the company’s stock incentive plan, vesting 25% on February 28, 2026 and 25% on January 31 of each following year until fully vested. As of this Form 4 filing, he beneficially owns 30,897 common shares, including outstanding and unvested RSUs and performance-based RSUs.

Rhea-AI Summary

MANHATTAN ASSOCIATES INC senior vice president Linda C. Pinne reported stock-based compensation awards in the form of common shares. On January 22, 2026, she acquired 798 shares and 217 shares of common stock at a price of $0.0000 per share through grant or award transactions.

Footnotes explain these awards relate to performance-based restricted stock units granted under the company’s stock incentive plan, with vesting in 25% installments on February 28, 2026 and on January 31 of subsequent years until fully vested. As of the filing date, she beneficially owned 42,672 shares of common stock, including outstanding and unvested restricted stock units and performance-based units.

Rhea-AI Summary

Manhattan Associates EVP, Americas Sales Robert G. Howell reported stock-based compensation transactions. On January 22, 2026, he acquired 10,353 and 2,809 shares of common stock at a price of $0.00 per share through grant or award acquisitions under the company’s stock incentive plan.

Footnotes explain these come from performance-based restricted stock units granted on January 23, 2025 and July 30, 2025, vesting 25% on February 28, 2026 and 25% on January 31 of each following year until fully vested. As of the filing date, he beneficially owns 179,173 shares of common stock, including outstanding and unvested RSUs and unvested performance-based RSUs.

Rhea-AI Summary

Manhattan Associates Inc. director Eddie Capel reported an equity award on a Form 4. He acquired 19,877 shares of common stock through a grant classified as performance-based restricted stock units under the company’s stock incentive plan.

The award was granted on January 23, 2025 and vests over time, with 25% vesting on February 28, 2026 and an additional 25% vesting on January 31 of each following year until fully vested. The grant was made at no cash cost to Capel, reflecting equity-based compensation rather than an open-market share purchase.

Rhea-AI Summary

Manhattan Associates executive James Stewart Gantt reported two stock awards. On January 22, 2026, he acquired 10,353 and 2,809 shares of common stock at a price of $0.00 per share through grant or award transactions.

Footnotes explain these are performance-based restricted stock units granted under the company’s stock incentive plan, with 25% scheduled to vest on February 28, 2026 and 25% on January 31 of each following year until fully vested. As of the filing date, he beneficially owns 69,582 shares of common stock, including outstanding and unvested RSUs and performance-based RSUs.

Rhea-AI Summary

Manhattan Associates President & CEO Eric Andrew Clark reported two equity transactions in company stock. On January 22, he acquired 16,214 shares at a price of $0.00 per share as a grant or award under the company’s stock incentive plan, tied to performance-based restricted stock units granted on January 23, 2025 that vest 25% on February 28, 2026 and 25% on January 31 each year thereafter until fully vested. On February 14, he disposed of 4,758 shares of common stock at $140.45 per share through a tax-withholding disposition to cover exercise price or tax liabilities, leaving him with 95,233 shares held directly after that transaction.

Rhea-AI Summary

Manhattan Associates EVP, CFO & Treasurer Dennis B. Story reported an equity award of 13,668 shares of common stock on February 4, 2026. The shares were acquired at a price of $0.0000 per share as part of the company’s stock incentive plan, reflecting non-cash compensation.

The award represents restricted stock units that vest in 25% installments on January 31 of each year following the grant date until fully vested. Following this grant, Story beneficially owns 107,945 shares of Manhattan Associates common stock in direct form.

Rhea-AI Summary

Manhattan Associates executive Bruce Richards reported a stock award. As SVP, CLO & Secretary, he received 3,417 shares of common stock on February 4, 2026 at a price of $0.0000 per share under the company’s stock incentive plan. These are restricted stock units that vest 25% each January 31 following the grant date until fully vested. After this grant, Richards directly holds 26,329 shares of Manhattan Associates common stock.

Rhea-AI Summary

Manhattan Associates executive Linda C. Pinne, SVP and Global Corporate Controller, received an award of 2,050 shares of common stock on 02/04/2026. These were granted as restricted stock units under the company’s stock incentive plan at a price of $0.0000 per share.

The restricted stock units vest 25% on January 31 of each year following the grant date until they are fully vested. After this grant, Pinne beneficially owns 41,657 shares of common stock directly.

Rhea-AI Summary

Manhattan Associates executive Robert G. Howell, EVP, Americas Sales, was granted 13,668 shares of common stock on February 4, 2026 at a price of $0.0000 per share under the company’s stock incentive plan. After this award, he beneficially owns 166,011 common shares directly.

The grant represents restricted stock units that vest in four equal installments of 25% each year on January 31 following the grant date until fully vested, aligning a portion of his compensation with long-term company performance.

Rhea-AI Summary

Manhattan Associates executive James Stewart Gantt received 13,668 restricted stock units on February 4, 2026. These were granted at no cash cost under the company’s stock incentive plan and are tied to the company’s common stock.

The award vests in equal 25% installments each January 31 following the grant date until fully vested, meaning the units convert into shares over four years as conditions are met. After this grant, Gantt beneficially owned 56,420 shares of Manhattan Associates common stock directly.

Rhea-AI Summary

Manhattan Associates President & CEO and director Eric Andrew Clark reported two transactions in the company’s common stock. On January 31, 2026, he disposed of 878 shares at $151.01 per share under code F, leaving 49,608 shares directly owned. On February 4, 2026, he acquired 34,169 shares at $0.0000 per share through a grant of restricted stock units under the company’s stock incentive plan, which vest 25% on January 31 of each year following the grant date until fully vested, increasing his direct beneficial ownership to 83,777 shares.

Rhea-AI Summary

Manhattan Associates director Eddie Capel reported a disposition of company common stock. On January 31, 2026, a transaction coded "F" involved 26,263 shares of common stock at $151.01 per share, leaving him with 136,725 shares held directly.

Rhea-AI Summary

Manhattan Associates Inc. executive Dennis B. Story, EVP, CFO & Treasurer, reported a Form 4 insider transaction in the company’s common stock. On 01/31/2026, he executed a transaction coded "F" involving 9,541 shares at $151.01 per share. Following this transaction, he directly beneficially owns 94,277 shares of Manhattan Associates common stock.

Rhea-AI Summary

Manhattan Associates executive Robert G. Howell reported a stock transaction involving company common shares. On 01/31/2026, he disposed of 8,202 shares of Manhattan Associates common stock at a price of $151.01 per share in a single reported transaction coded "F." Following this transaction, he directly beneficially owned 152,343 shares of common stock. Howell serves as Executive Vice President, Americas Sales, and the filing reflects his updated direct ownership position.

Rhea-AI Summary

Manhattan Associates Inc. insider activity: Senior Vice President, Chief Legal Officer and Secretary Bruce Richards reported a disposition of common stock. On 01/31/2026, he disposed of 2,339 shares of Manhattan Associates common stock at a reported price of $151.01 per share. Following this transaction, he directly beneficially owned 22,912 shares of the company.

Rhea-AI Summary

Manhattan Associates executive James Stewart Gantt reported a Form 4 transaction involving company common stock. On January 31, 2026, he disposed of 6,416 shares of Manhattan Associates common stock at a reported price of $151.01 per share under transaction code F.

After this transaction, Gantt beneficially owned 42,752 shares of common stock, held directly. He is identified as an officer of the company, serving as EVP, Professional Services, and this filing reflects his updated ownership position.

Rhea-AI Summary

Manhattan Associates senior vice president and global corporate controller Linda C. Pinne reported a disposition of common stock in a Form 4 filing. On 01/31/2026, 1,292 shares of common stock were disposed of at a price of $151.01 per share. Following this transaction, she beneficially owns 39,607 shares of Manhattan Associates common stock directly.

Rhea-AI Summary

Manhattan Associates (MANH) director reported an internal transfer of shares. On October 21, 2025, the reporting person moved 20,808 shares of common stock to a revocable trust for $0.0000 consideration (transaction code G). After the transfer, the filer beneficially owns 1,330 shares directly and 20,808 shares indirectly through the trust. The reporting person and spouse serve as trustees. This Form 4 reflects a change in ownership form rather than an open‑market sale.